Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2016 Mar 30;2016:bcr2015209934. doi: 10.1136/bcr-2015-209934

Xanthogranulomatous pancreatitis mimicking a malignant solid tumour

Viswanath Atreyapurapu 1, Abhinav Keshwani 2, Ramachandra Lingadakai 1, Kanthilatha Pai 3
PMCID: PMC4823535  PMID: 27030447

Abstract

Xanthogranulomatous inflammation, which is known to occur in several viscera, is rarely found to affect the pancreas. We report a case of xanthogranulomatous pancreatitis (XGP) occurring in a 60-year-old man who presented with epigastric pain and vomiting. Physical examination did not reveal any abnormality. Contrast-enhanced CT of the abdomen revealed an ill-defined, heterogeneous mass lesion in the uncinate process of the pancreas, suggestive of malignancy. Whipple's pancreaticoduodenectomy was performed and the final pathological diagnosis was XGP. The patient's postoperative course was uneventful. When a pancreatic mass does not show clinicoradiological features typical of common pancreatic neoplasms, XGP should be considered for a differential diagnosis and duodenum preserving surgery can be considered.

Background

The occurrence of xanthogranulomatous inflammation (XGI) in the pancreas is extremely rare. Only 14 cases of xanthogranulomatous pancreatitis (XGP) have been reported to date. The presented report is the third case from India.

Case presentation

A 60-year-old man presented with epigastric pain radiating to the back for 1 month and three episodes of non-bilious vomiting in the last 1 week. He had lost 5 kg over the last 3 months. His appetite was normal. He underwent laparoscopic cholecystectomy 1 year earlier for symptomatic gallstone disease. The histopathology of the gallbladder was reported as chronic follicular cholecystitis. Physical examination showed no abnormality.

Investigations

CT of the abdomen showed an ill-defined lesion with predominant irregular peripheral enhancement and internal necrotic areas having possible continuity with the uncinate process of the pancreas and infiltration of the superior wall of the third and fourth parts of the duodenum (figure 1). CT guided fine needle aspiration cytology of the mass was suspicious of malignancy. Serum carcinoembryonic antigen was 2.9 ng/mL and CA 19.9 was <0.60 U/mL. Serum amylase and serum lipase were 64 and 34 U/L, respectively.

Figure 1.

Figure 1

Ill-defined heterogeneous mass lesion with predominant irregular peripheral enhancement and internal necrotic areas with possible continuity with the uncinate process.

Treatment

The patient underwent Whipple's pancreaticoduodenectomy. Intraoperatively, growth was found in the uncinate process of the pancreas, not infiltrating the SMA, superior mesenteric artery/SMV, superior mesenteric vein (SMA/SMV)/portal vein.

Gross examination of the pancreas showed a large area of necrosis surrounded by yellowish-white areas (figures 2 and 3). Microscopic examination showed areas of necrosis surrounded by sheets of foamy macrophages and chronic inflammatory cells with foreign body giant cells. Surrounding pancreatic parenchyma showed atrophy and inflammatory atypia of acinar cells (figures 4 and 5), suggesting a diagnosis of XGP.

Figure 2.

Figure 2

Gross specimen of Whipple's resection for suspected pancreatic carcinoma: Inset—shows pancreatic parenchyma (black arrow) with a large irregular area of necrosis and yellowish-white areas of xanthogranulomatous inflammation (red arrow).

Figure 3.

Figure 3

Photomicrograph showing large area of necrosis above and dense inflammation destroying the pancreatic parenchyma below, H&E, ×100. Inset—photomicrograph showing dense inflammation composed of neutrophils, sheets of foamy macrophages and occasional foreign body giant cells, H&E, ×200.

Figure 4.

Figure 4

Small focus of calcification noted within the mass.

An accessory right hepatic artery was found to arise from the SMA (video 1).

Video 1.

Download video file (8.9MB, mp4)
DOI: 10.1136/bcr-2015-209934.video01

An accessory right hepatic artery arising from the superior mesenteric artery.

Outcome and follow-up

The patient's immediate postoperative period was uneventful. He was discharged on the 10th postoperative day after ensuring drain fluid amylase and bilirubin were normal. He was followed every 2 weeks on an OPD basis. He was asymptomatic and had a normal diet. Ultrasonogram of the abdomen after 1 month was normal.

Discussion

XGI is a form of chronic mixed inflammatory process characterised by lipid-laden histiocyte aggregation and mass formation. Fairly large numbers of cases of xanthogranulomatous cholecystitis and pyelonephritis have been reported with several hypothesis including haemorrhage, immunological conditions, reaction to a specific infectious agent of low virulence (more likely for pyelonephritis), defective lipid transport and lymphatic obstruction. Bile extravasation in the gallbladder wall secondary to the rupture of Rokitansky-Aschoff sinuses and mucosal ulcer is one of the proposed hypothesis for xanthogranulomatous cholecystitis.1 The pathogenesis of XGP is not well understood. Several hypotheses have been suggested for XGP based on the risk factors and clinicopathological findings. Ueno et al2 reported XGI in the wall of a pancreatic pseudocyst, it could have been due to infection and haemorrhage in a cyst formed by cystic neoplasm, or after pancreatitis and increased intracystic pressure, leading to XGI around the pancreatic cyst wall. Kim et al3 advocated increased indraductal pressure and subsequent leak of mucin into the pancreatic parenchyma due to increase mucin production by intraductal papillary mucinous tumour. Iyer et al4 reported XGP as mass lesions with a history of gall stones, which might have led to obstruction of the pancreatic duct and thus inflammatory changes, as in our case.

As described in the present case and previous reports, most cases of XGP mimic primary pancreatic neoplasms. The CT findings of xanthogranulomatous pyelonephritis are calcification, increase in renal volume, hydronephrosis and hypodense areas depicting parenchymal destruction filled with either pus or debris. This disease process shares many characteristics with a true neoplasm.5 CT findings in xanthogranulomatous cholecystitis show marked gallbladder wall thickening and bladder wall often containing nodules, hypoattenuating at CT, that may be abscesses or foci of XGI. These features overlap with those of gallbladder carcinoma, often making preoperative distinction between these entities impossible.6 The efficacy of fluorodeoxyglucose positron emission tomography for differentiating malignant from benign pancreatic lesions remains debatable.7 However, we did not perform other imaging, such as MRI and PET scan, as the patient could not afford it.

All the cases reported to date have been from Asian countries, and have had a male predominance (M:F—11:4). The location of the lesions were the head (6/15), body (5/15) and tail (4/15). Importantly, the preoperative diagnosis in 9 cases (9/15) was malignancy. Pseudo cyst and chronic pancreatitis were diagnosed in three cases each (table 1). All the cases, including ours, were treated with surgery. It is difficult to differentiate XGP from true neoplastic lesions preoperatively using imaging techniques and image-guided biopsy, as in our case. Although this type of pancreatitis is extremely rare, it is important for surgeons, pathologists and radiologists to recognise this uncommon entity.

Learning points.

  • Xanthogranulomatous pancreatitis should be considered in the differential diagnosis of a pancreatic mass.

  • Inflammatory atypia of acinar cells of the pancreas may be mistaken for malignant cells in fine needle aspiration cytology (FNAC), particularly when clinically suspicious for malignancy. Hence, final diagnosis can only be made on the histopathological sample.

  • It is difficult to differentiate XP from malignancy though calcification on CT (figure 6), and a well-defined margin can be considered in favour of XP.

  • Predominance in Asian males and association with gall stones can be areas of further study.

  • Duodenum-preserving pancreatic head resection, which has less morbidity and mortality, can be performed if XGP is diagnosed preoperatively using fine needle aspiration cytology, or by frozen section.

Table 1.

Author Year Age/sex Symptoms History of gall stone disease Preoperative diagnosis Gross appearance Site FNAC Operation
Uneo2 1993 42/M Abdominal pain Nil Pseudo cyst Cystic Body No Distal pancreatectomy
Iyer4 2004 50/M Jaundice Cholelithiasis Malignancy Nodular Head Yes Whipple's operation
Iyer 2004 36/M Stone Choledocolethiasis Malignancy Massive Tail Yes Mass excision
Kamitani 2005 82/M Epigastric pain Nil IPMT Cystic Body No Whipple's operation
Kang BW 2007 22/F Abdominal pain Nil Chronic pancreatitis solid Head No PPPD
Okabayshi 2007 60/M Abdominal pain Nil Pseudo cyst Cystic Tail No Distal pancreatectomy
Okabayshi 2007 69/M Abdominal pain Nil Pseudo cyst Cystic Tail No Distal pancreatectomy
Shima 2008 66/M Epigastric pain Nil Malignancy Solid Body No Distal pancreatectomy
Iso 2008 82/M Weight loss Nil IPMC Nodular Tail No Distal pancreatectomy
Ikeura 2009 73/M Abdominal pain Nil SPPT Cystic Body No PPPD
Uguz 2010 30/M Abdominal pain Nil Chronic pancreatitis Head No DPP
Uguz 2010 34/F Abdominal pain Nil Chronic pancreatitis Head No DPP
Kim YN3 2010 72/F Abdominal pain Nil IPMT Cystic Body No PPPD
Kim SH8 2011 70/F Abdominal pain Nil Malignancy Solid Head No Whipple's operation
Present case 2015 60/M Abdominal pain Cholelithiasis Malignancy Solid Head Yes Whipple's operation

DPPD, duodenum preserving pancreatectomy; FNAC, fine needle aspiration cytology; IPMC, intraductal papillary mucinous carcinoma; IPMT, intraductal papillary mucinous tumour; PPPD, pylorus preserving pancreato-duodenectomy; SPPT, solid pseudo papillary tumour.

Footnotes

Competing interests: None declared.

Patient consent: Obtained.

Provenance and peer review: Not commissioned; externally peer reviewed.

References

  • 1.Houston JP, Collins MC, Cameron I et al. Xanthogranulomatous cholecystitis. Br J Surg 1994;81:1030–2. 10.1002/bjs.1800810735 [DOI] [PubMed] [Google Scholar]
  • 2.Ueno T, Hamanaka Y, Nishihara K et al. Xanthogranulomatous change appearing in the pancreas cyst wall. Pancreas 1993;8:649–51. 10.1097/00006676-199309000-00020 [DOI] [PubMed] [Google Scholar]
  • 3.Kim YN, Park SY, Kim YK et al. Xanthogranulomatous pancreatitis combined with intraductal papillary mucinous carcinoma in situ. J Korean Med Sci 2010;25:1814–17. 10.3346/jkms.2010.25.12.1814 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Iyer VK, Aggarwal S, Mathur M. Xanthogranulomatous pancreatitis: mass lesion of the pancreas simulating pancreatic carcinoma—a report of two cases. Indian J Pathol Microbiol 2004;47:36–8. [PubMed] [Google Scholar]
  • 5.Kim JC. US and CT findings of xanthogranulomatous pyelonephritis. Clin Imaging 2001;25:118–21. 10.1016/S0899-7071(01)00262-5 [DOI] [PubMed] [Google Scholar]
  • 6.Levy AD, Murakat LA, Abbott RM et al. From the archives of the AFIP. Benign tumors and tumorlike lesions of the gallbladder and extrahepatic bile ducts: radiologic-pathologic correlation. Armed Forces Institute of Pathology. Radiographics 2002;22:387–413. 10.1148/radiographics.22.2.g02mr08387 [DOI] [PubMed] [Google Scholar]
  • 7.Mansour JC, Schwartz L, Pandit-Taskar N et al. The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas. J Gastrointest Surg 2006;10:1354–60. 10.1016/j.gassur.2006.08.002 [DOI] [PubMed] [Google Scholar]
  • 8.Kim HS, Joo M, Chang SH et al. Xanthogranulomatous pancreatitis presents as a solid tumor mass: a case report. J Korean Med Sci 2011;26:583–6. 10.3346/jkms.2011.26.4.583 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES